Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)

Clinical trial NCT07513233 · RECRUITING

Trial details

NCT number: NCT07513233
Sponsor: Capital Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2026-04-28
Primary completion: 2026-08-20
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.